A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...
Please provide your email address to receive an email when new articles are posted on . Elevated postoperative serum carcinoembryonic antigen increased risk for recurrence, especially within the first ...
Carcinoembryonic antigen (CEA) monitoring in patients with stage I-IV colorectal cancer has been, and remains, a controversial issue in oncology practice. Recommendations vary from bimonthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results